Utility of routine laboratory testing in management of chronic urticaria/angioedema

Ann Allergy Asthma Immunol. 2011 Sep;107(3):239-43. doi: 10.1016/j.anai.2011.06.008. Epub 2011 Jul 20.

Abstract

Background: Laboratory tests are routinely ordered to identify or rule out a cause in patients with chronic urticaria/angioedema (CUA). The results of these tests are usually within normal limits or unremarkable.

Objective: To investigate the proportion of abnormal test results in patients with CUA leading to a change in management and in outcomes of care.

Methods: Retrospective analysis of a random sample of adult patients with CUA from 2001-2009.

Results: Cases totaled 356: 166 with urticaria and angioedema (AE), 187 with urticaria, and 3 with only AE. Patients were predominately women (69.1%) and white (75.6%), with a mean age of 48 ± 15 years. Abnormalities were commonly seen in complete blood counts (34%) and in complete metabolic panels (9.4%). Among the 1,872 tests that were ordered, results of 319 (17%) were abnormal. Of 356 patients, 30 underwent further testing because of abnormalities in laboratory work. This represented 30 of 1,872 tests (1.60%). Only 1 patient benefited from a subsequent change in management.

Conclusions: Laboratory testing in CUA patients referred for an Allergy and Immunology evaluation rarely lead to changes in management resulting in improved outcomes of care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angioedema / diagnosis*
  • Angioedema / drug therapy*
  • Blood Cell Count
  • Chronic Disease
  • Diagnostic Tests, Routine*
  • Doxepin / therapeutic use
  • Female
  • Histamine Antagonists / therapeutic use
  • Humans
  • Laboratories, Hospital / economics
  • Male
  • Metabolic Networks and Pathways
  • Middle Aged
  • Retrospective Studies
  • Sex Factors
  • Treatment Outcome

Substances

  • Histamine Antagonists
  • Doxepin